Pancreatic ductal adenocarcinoma (PDAC) remains one of the most treatment-refractory malignancies, with limited and often transient benefit from chemotherapy, targeted therapy, immunotherapy, and radiotherapy. Therapeutic resistance is increasingly recognized as an ecosystem-level process arising from reciprocal intera...
Hong-Jiao Li, Jia-Ning Cui, Xin Yang et al.· Cancer Drug Resistance· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.